99mTc-EthyIenedicysteine-Folate: A new tumor imaging agent. synthesis, labeling and evaluation in animals

Cancer Biotherapy and Radiopharmaceuticals

Volumn 13, Issue 6, 1998, Pages 427-435

  Ilgan, Seyfettin ^a   Yang, David J ^a,b   Higuchi, Tetsuya ^a   Zareneyrizi, Fereshteh ^a   Bayhan, Hikmet ^a   Edmund Kim, E ^a   Podoloff, Donald A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Ethylenedicysteine; Folate receptor; Te; Tumor imaging

Indexed keywords

CHELATING AGENT; ETHYLENEDICYSTEINE FOLATE TC 99M; FOLIC ACID; MEMBRANE RECEPTOR; N,N' ETHYLENEDICYSTEINE TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; CYSTEINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; TECHNETIUM COMPLEX; TECHNETIUM TC 99M ETHYLENEDICYSTEINE FOLATE; TECHNETIUM TC 99M-ETHYLENEDICYSTEINE-FOLATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BREAST TUMOR; CONTROLLED STUDY; DOG; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TISSUE LEVEL; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION; TUMOR SCINTISCANNING; ANIMAL; CHEMICAL STRUCTURE; EXPERIMENTAL NEOPLASM; FISCHER 344 RAT; SCINTISCANNING; SYNTHESIS;

ANIMALS; AUTORADIOGRAPHY; CYSTEINE; FEMALE; INDICATORS AND REAGENTS; MAMMARY NEOPLASMS, EXPERIMENTAL; MOLECULAR STRUCTURE; ORGANOTECHNETIUM COMPOUNDS; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; RATS; RATS, INBRED F344; TISSUE DISTRIBUTION;

EID: 0032216520     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1998.13.427     Document Type: Article

References (50)

1. Goldsmith SJ. Receptor imaging: Competitive or complementary to antibody imaging. Semin ffuclMed 1997; 27: 85-93.
2. Britton KE, Granowska M. Imaging of tumors, in tomography in nuclear medicine. Proceedings of an International Symposium, Vienna, Austria, IAEA, 1996, pp 91-105.
3. Krenning EP, Kwekkeboom DJ, Bakker WH, et al.Somatostatin receptor scintigraphy with [In-111DTPA-D-Phe] and [I-123-Tyr]-octretide: The Rotterdam experience with more than 1000 patients. EnrJNucI Med 1995; 7:716-731.
4. Reubi JC, Krenning EP, Lamberts SWJ, et al. In vitro detection of somatostatin receptors in human tumors. Metabolism 1992; 41:104-110 (suppl 2).
5. Goldsmith SJ, Macapinlac H, O'Brien JP. Somatostatin receptor imaging in lymphoma. Semin Nucl Med 1995; 25:262-271.
6. Virgolini I, Raderer M, Kurtaran A. Vasoactive intestinal peptide (W) receptor imaging in the localization of intestinal adenocarcinomas and endocrine tumors. N Eng J Med 1994; 331:1116-1121.
7. Westerhof GR, Jansen G, Emmerik NV, Kathmann I, Rijksen G, Jackman AL, Schomagel JH. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: Role of carrier- and receptor-mediated transport systems. Cancer Res 1991; 51:5507-5513.
8. Orr RB, Kreisler AR, Kamen BA. Similarity of folate receptor expression in UMSCC 38 cells to squamous cell carcinoma differentiation markers. JNatl Cancer Inst 1995; 87:299-303.
9. Hsueh CT, Dolnick BJ. Altered folate-binding protein mRNA stability in KB cells grown in folate-deficient medium. Biochem Pharmacol 1993; 45:2537-2545.
10. Weitman SD, Lark RH, Coney LR, et al. Distribution of folate GP38 in normal and malignant cell lines and tissues. Cancer Res 1992; 52:3396-3400.
11. Campbell IG, Jones TA, Foulkes WD, Trowsdale J. Folate-binding protein is a marker for ovarian cancer. Cancer Res 1991; 51:5329-5338.
12. Weitman SD, Weinberg AG, Coney LR, Zurawski VR, Jennings DS, Kamen BA. Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res 1992; 52:6708-6711.
13. Holm J, Hansen SI, Hoier-Madsen M, Sondergaard K, Bzorek M. Folate receptor of human mammary adenocarcinoma. APMIS 1994; 102:413-419.
14. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissue in vivo and in established cell lines. Cancer 1994; 73:2432-2443.
15. Franklin WA, Waintrub M, Edwards D, Christensen K, Prendegrast P, Woods J, Bunn PA, Kolhouse JF. New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma. Int J Cancer-Supplement 1994; 8:89-95.
16. Weitman SD, Frazier KM, Kamen B A. The folate receptor in central nervous system malignancies of childhood. J Neuro-Oncology 1994; 21:107-112.
17. Ginobbi P, Geiser TA, Ombres D, Citro G. Folie acidpolylysine carrier improves efficacy of c-myc antisense oligonucleotides on human melanoma (M14) cells. Anticancer Res 1997; 17:29-35.
18. Leamon CP, Low PS. Delivery of macromolecules into living cells: a method that exploits folate receptor endocylosis.ProcNatlAcadSci 1991; 88:5572-5576.
19. Leamon CP, Low PS. Cytotoxicity of momordin-folate conjugates in cultured human cells. J Biol Chem 1992; 267:24966-24971.
20. Leamon CP, Pastan I, Low PS. Cytotoxicity of folatepseudomonas exotoxin conjugates toward tumor cells. JBiolChem 1993; 268:24847-24854.
21. Lee RJ, Low PS. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. JBiol Chem 1994; 269:3198-3204.
22. Ginobbi P, Geiser TA, Ombres D, Citro G. Folie acidpolylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (Ml 4) cells. Anticancer Res 1997; 17:29-35.
23. Canevari S, Miotti S, Bottero F, Valota O, Colnaghi MI. Ovarian carcinoma therapy with monoclonal antibodies. Hybridoma 1993; 12:501-507.
24. Bolhuis RLH, Lamers CHJ, Goey HS, et al. Adoptive immunotherapy of ovarian carcinoma with Bs-MAb targeted lymphocytes. A multicenter study. Int J Cancer 1992; 7:78-81.
25. Patrick TA, Kranz DM, van Dyke TA, Roy EJ. Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice. J Nenrooncol 1997; 32:111-123.
26. Coney LR, Mezzanzanica D, Sanbom D, Casalini P, Colnaghi MI, Zurawski VR. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing. Cancer Res 1994; 54:2448-2455.
27. Kranz DM, Patrick TA, Brigle KE, Spinella MJ, Roy EJ. Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis. Proc NatlAcad Sci 1995; 92:9057-9061.
28. Mathias CJ, Wang S, Lee RJ, Waters DJ, Low PS, Green MA. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of Gallium67-deferoxamine-folate. JNuclMed 1996; 37:10031008.
29. Wang S, Luo J, Lantrip DA, Waters DJ, Mathias CJ, Green MA, Fuchs PL, Low PS. Design and synthesis of ['In]DTPA-folate for use as a tumor-targeted radiopharmaceutical. Bioconjugate Chem 1997; 8:673679.
30. Wang S, Lee RJ, Mathias CJ, Green MA, Low PS. Synthesis, purification, and tumor cell uptake of Ga-67 deferoxamine-folate, a potential radiopharmaceutical for tumor imaging. Bioconjugate Chem 1996; 7:56-62.
31. Mathias CJ, Wang S, Waters DJ, Turek JJ, Low PS, Green MA. Indium-111-DTPA-folate as a radiopharmaceutical for targeting tumor-associated folate binding protein (Abstract). J Nucl Med 1997 (Supplement); 38:133P.
32. Mathias CJ, Hubers D, Trump DP, Wang S, Luo.J, Waters DJ, Fuchs PL, Low PS, Green MA. Synthesis of Tc-99m-DTPA-folate and preliminary evaluation as a folate-receptor-targeted radiopharmaceutical (Abstract). JNuclMed 1997 (Supplement); 38:87P.
33. Davison A, Jones AG, Orvig C, Sohn M. A new class of oxotechnetium(+5) chelate complexes containing a TcON2S2 Core. Inorg Chem 1980; 20:1629-1632.
34. Verbruggen AM, Nosco DL, Van Nerom CG, et al. Tc99m-L,L-ethylenedicysteine: A renal imaging agent. I.Labelling and evaluation in animals. JNuclMed 1992; 33:551-557.
35. Van Nerom CG, Bormans GM, De Roo MJ, et al. First experience in healty volunteers with Tc-99m-L,Lethylenedicysteine, a new renal imaging agent. Eur J NuclMed 1993; 20:738-746.
36. Surma MJ, Wiewiora J, Liniecki J. Usefulness of Tc99m-N,N'-ethylene-l-dicysteine complex for dynamic kidney investigations. Nucl Med Comm 1994; 15:628635.
37. Verbruggen A, Nosco D, Van Nerom C, Bormans G, Adriaens P, De Roo M. Evaluation of Tc-99m L,Lethylenedicysteine as a potential alternative to Tc-99m MAG3. Eur JNuclMed 1990; 16:429.
38. Van Nerom C, Bormans G, Bamvens J, Vandecrays A, De Roo M, Verbruggen A. Comparative evaluation of Tc-99m L,L-ethylenedicysteine and Tc-99m MAG3 in volunteers. EurJ Nucl Med 1990; 16:417.
39. Jamar F, Stoffel M, Van Nerom C, et al. Clinical evaluation of Tc-99m L,L-ethylenedicysteine, a new renal tracer, in transplanted patients. J Nucl Med 1993 ; 34:129P.
40. Jamar F, Van Nerom C, Verbruggen A, et al. Clearance of the new tubular agent Tc-99m L^L-ethylenedicysteine: Estimation by a simplified method. J Nucl Med 1993; 34:129P.
41. Ratner S, Clarke HT. The action of formaldehyde upon cysteine. J Am ChemSoc 1937; 59:200-206.
42. Blondeau P, Berse C, Gravel D. Dimerization of an intermediate during the sodium in liquid ammonia reduction of L-thiazolidine-4-carboxylic acid. CanJ Chem 1967; 45:49-52.
43. Gucalp R, Dutcher JP, Wiernik. Overwiev by an oncologist: What are the imaging needs of the oncologist and oncological surgeon. Semin Nucl Med 1997; 27:3-9.
44. Crippa F, Buraggi GL, Di Re E, et al. Radioimmunoscintigraphy of ovarian cancer with the MOvl 8 monoclonal antibody. EurJ Cancer 1991; 27:724-729.
45. Paganelli G, Belloni C, Magnani P, et al. Two-step tumour targetting in ovarian cancer patients using biotinylated monoclonal antibodies and radiactive streptavidin. Eur J Nucl Med 1992; 19:322-329.
46. Chung KN, Saiwaka Y, Paik TH, et al. Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates. J Clin Invest 1993; 91:1289-1294.
47. Deutsch JC, Elwood PC, Portillo RM, Macey MG, Kolhouse JF. Role of membrane-associated folate binding protein (folate receptor) in methotrexate transport by human KB cells. Arch Biochem Biophysics 1989; 274:327-337.
48. Kane MA, Portillo RM, Elwood PC, Antony AC, Kolhouse JF. The influence of extracellular folate concentration on methotrexate uptake by human KB cells. JBiol Chem 1986; 261:44-49.
49. Wang X, Shen F, Freisheim JH, Gentry LE, Ratnam M. Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates. Biochem Pharmacol 1992; 44:1898-1901.
50. Sierra EE, Brigle KE, Spinella MJ, Goldman ID. pH depedence of methotrexate transport by the reduced folate carrier and the folate receptor in LI 210 leukemia cells. Further evidence for a third route mediated at low pH. Biochem Pharmacol 1997; 53:223-231.